Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-24
2006-10-24
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S310000, C546S143000, C546S144000
Reexamination Certificate
active
07125891
ABSTRACT:
The present invention is concerned with novel compounds of formula (I) which are inhibitors of a membrane tripeptidyl peptidase responsible for the inactivation of endogenous neuropeptides such as cholecystokinis (CCKs). The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use as a medicine of said compounds.wherein n is an integer 0 or 1; X represents O; S; or —(CR4R5)m— wherein m is an integer 1 or 2; R4and R5are each independently from each other hydrogen or C1-4alkyl; R1is C1-6alkylcarbonyl optionally substituted with hydroxy; C1-6alkyloxycarbonyl; aminoC1-6alkylcarbonyl wherein the C1-6alkyl group is optionally substituted with C3-6cycloalkyl; mono- and di(C1-4alkyl)aminoC1-6alkylcarbonyl; aminocarbonyl substituted with aryl; C1-6alkylcarbonyloxyC1-6alkylcarbonyl; C1-6alkyloxycarbonylaminoC1-6alkylcarbonyl wherein the amino group is optionally substituted with C1-4alkyl; an amino acid; C1-6alkyl substituted with amino; or arylcarbonyl; R2is an optionally substituted 5-membered heterocycle, or R2is optionally substituted benzimidazole; R3is a bivalent radical —CH2CH2— optionally substituted with halo or phenylmethyl; or R3is a bivalent radical of formula
REFERENCES:
patent: 3023235 (1962-02-01), Frederick
patent: 3763218 (1973-10-01), Hohenlohe et al.
patent: 4563306 (1986-01-01), Ishida et al.
patent: 5610144 (1997-03-01), Capet et al.
patent: 2002/0161189 (2002-10-01), Lazarus et al.
patent: 0506468 (1992-09-01), None
patent: 2 735 776 (1996-12-01), None
patent: 2 735 776 (1996-12-01), None
patent: 5339240 (1993-12-01), None
patent: WO 96/06855 (1996-03-01), None
patent: WO 99/33801 (1999-07-01), None
patent: WO 99/55679 (1999-11-01), None
patent: WO 02/36116 (2002-05-01), None
Database Crossfire Beilstein 'Online! Beilstein Institut zur Foerderung Der Wissenschaften, Frankfurt, DE, BRN 543350 XP-002199741 abstract (1995).
D.S.Fries, Analgesics, Principles of Medicinal Chemistry, 4thEd; W.O. Foye, T.L. Lemke, and D.A. Williams, Eds, Williams and Wilkins, Baltimore, Md. 1995, pp. 247-269.
J.V. Aldrich, Analgesics, Burgers' Medicinal Chemistry and Drug Discovery, 5thEdition, vol. 3, Therapeutic Agents, John Wiley & sons, Inc. 1996, pp. 321-441.
J.M. P. Riviere et al., Opioid receptors: Targets for new gastrointestinal drug development, Drug Development 2000, pp. 203-238.
B.J. Marsden et al., Spontaneous degradation via diketopiperazine formation of peptides containing a tetrahydroisoquinoline-3-carboxylic acid residue in the 2 -position of the peptide sequence, Int. J. Pept. Protein Res. 1993, 41(3) pp. 313-316.
M.P. Wentland et al., 3-Carboxamido Analogues of Morphine and Naltrexone: Synthesis and Opioid Receptor Binding Properties, Biorganic & Medicinal Chemistry Letterss, 2001, (11) pp. 1717-1721.
M.P. Wentland et al., 8-Carboxamidocyclazocine Analogues: Redefiningg the Structure-Activity Relationships of 2,6-Methano-3-benzazocines, Biorganic & Medicinal Chemistry Letters, 2001, (11)pp. 623-626.
P.L. Gould, Salt selection for basic drugs, International Journal of Pharmaceutics, vol. 33, 1986, pp. 201-217.
S. M. Berge et al., Pharmaceutical Salts, Journal of Pharmaceutical Sciences, 1977, Jan. vol. 66, No. 1, pp. 1-19.
Tao Ye et al. Synthesis of Chiral N-Protected α-Amino-β-Diketones from α-Diazoketones Derived from Natural Amino Acids, Tetrahedron 1992, vol. 48, No. 37, pp. 8007-8022.
H. Maeda, et al., Synthesis and Central Nervous System Actions of Thyrotropin-Releasing Hormone Analogs Containing a 1-Oxo-1,2,3,4-tetrahydroisoquinoline Moiety1, Chem. Pharm, Bull. 36(1)1988, pp. 190-201.
H. Obase et al., New Antihypertensive Agents II. Studies on New Analog of 4-Piperidylbenzimidazolinones, Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan, Tokyo, Up. vol. 30, No. 2, 1982, pp. 474-483, XP000974108.
Tripp et al., Synthesis of methylene-and carbonyl-bridged analogs of iodothyronines and iodothyroacetic acids, Journal of Medicinal Chemistry, American Chemical Society, Washington, U.S. vol. 16, No. 1 1973, pp. 60-64, XP002113321.
P.J. Krenitsky et al., Preparation of the 14-membered 1,1-cyloisodityrosine subunit of RP 66453, Tetrahedron Letters, Elsevier Science Publishers, Amsterdam, NL vol. 43, No. 3, Jan. 14, 2002, pp. 407-410, XP004329390.
F. Leonard, Unnatural amino acids. II. Congeners of DL-3-carboxy-4-methoxyphonylalanine. J. Med. Chem. vol. 10, 1967, pp. 478-481, XP 00258212.
G. Balboni et al., Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei, Peptides 2000, 21, pp. 1663-1671.
G. Balboni et al., Evaluation of the Dmt-Tic Pharmaceophore: Conversion of a Potent—Opioid Receptor Antagonist into a Potent Agonist and Ligands with Mixed Properties, J. Med. Chem., 2002, 45, pp. 713-720.
M. A. Hoitink et al., Degradation of Azaglycinamido Residues in Model Tripeptides Derived from Goserelin, Journal of Pharmaceutical Sciences, vol. 89, No. 1, Jan. 2000, pp. 108-114.
S. Salvadori et al., Evolution of the Dmt-Tic Pharmacophonre: n-Terminal Methylated Derivatives with Extraordinary Opioid Antagonist Activity, J. Med. Chem, 1997, 40, pp. 3100-3108.
H. Rapoport et al., 2,2-Bipyrrole, Journal of the American Society, vol. 84, 1962, pp. 2178-2181.
P. Wipf et al., Total Synthesis of (-)-Muscoride A, Journal of Organic chemistry, vol. 61, J. Org. Chem., 1996, pp. 6517-6522.
S. Borg et al., Synthesis of 1,2,4-Oxadiazole-, 1,34-Oxadiazole-, and 1,2,4-Triazole-Derived Dipeptidomimetics, Journal Organic Chemistry, vol. 60, 1995, pp. 3112-3120.
A. Dondoni et al., Addition of 2-Silylazoles to Heteroaryl Cations, Synthesis of Unsymmetrical Azadiaryls, Tetrahedron Letters, vol. 25, No. 33, 1984, pp. 3637-3640.
D. Fuhlhage et al., Studies on the Formation and Reactions of 1-Pyrroline1, Journal of American Chem. Soc., 1958, pp. 6249-6254.
M. Stanchev et al., Synthesis and Antimicrobial Activity in Vitro of New Amino Acids and Peptides Containing Thiazole and Oxazole Moieties, Arch. Pharm. Med. Chem., 1999, pp. 297-304.
M. Wuonola et al., Imidazole Alkaloids of Macrorungia Longistrobus Revised Structures and Total Syntheses, Tetrahedron, vol. 32, 1976, pp. 1085-1095.
K. Kikuchi et al., Synthesis and Structure-Activity Relationships of 5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline Derivatives with Retinoic Acid Receptor α Agonistic Activity, Journal of Medicinal Chemistry, 2000, vol. 43, No. 3, pp. 409-419.
Rose C et al., Characterization and Inhibition of A Cholecystokinin-Inactivating Serine Peptidase, Nature, MacMillan Journals, Ltd. London, GB, vol. 380, No. 6573, Apr. 4, 1996 pp. 403-409. XP002068304.
Dondoni A et al. Addition of 2-silylazoles to heteroaryl cations, synthesis of unsymmetrical azadiaryls, Tetrahedron Letters, Elsevier Science Publishers, Amsterdam, NL vol. 25, No. 33, 1984, pp. 3637-3640, XP002138665.
Database Biosis 'Online! Biosciences Information Service, Philadelphia, PA, US, 1976, Wuonola M.A. et al., Imidazole Alkaloids of Macrorungia-Longistrobus Revised Structures and total Syntheses, Database accession No. PREV197662056525, XP002199740 abstract.
Database Crossfire Beilstein 'Online! Beilstein Institut zur Foerderung Der Wissenschaften, Frankfurt, DE, BRN 165639, XP002199743 abstract.
Database Crossfire Beilstein 'Online! Beilstein Institut zur Foerderung Der Wissenschaften, Frankfurt, DE, BRN 8335691, 8332147, XP002199744 abstract.
WIPF P et al, Total Synthesis of (-)Muscoride A, Journal of Organic Chemistry, American Chemical Society, Easton, US, vol. 61, 1996, pp. 6517-6522, XP002199739, ISSN:0022-3263.
Borg S et al., Synthesis of 1,2,4-Oxadiazole-, 1,3,4-Oxadiazole, and 1,2,4-Triazole-Derived Dipeptidomimetrics, Journal of Organic Chemistry, American Chemical Society, Easton. US. vol. 60, No. 10, May 19, 1995, pp. 3112-3120, XP000973994, ISSN:0022-3263.
Database Crossfire Beilstein 'Online! Beilstein Institut zur Foerderung Der Wissenschaften, Frankfurt, DE BRN 524173, XP002199742 abstract.
Database Crossfire Beilstein 'Online! Beilstein Institut zur Fo
Breslin Henry Joseph
De Winter Hans Louis Jos
Kukla Michael Joseph
Freistein Andrew B.
Shameem Golam M. M.
LandOfFree
Tripeptidyl peptidase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tripeptidyl peptidase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tripeptidyl peptidase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3616716